• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PC - 904在儿科的临床研究(作者译)

[A clinical study of PC-904 in pediatrics (author's transl)].

作者信息

Hori M, Kono S, Hashimoto F

出版信息

Jpn J Antibiot. 1978 Jul;31(7):389-94.

PMID:691263
Abstract

A clinical study of PC-904 was performed in children. The results were as follows; 1) Serum levels of PC-904 after single administration of 20 mg/kg were studied in patients by one-shot intravenous injection or drip infusion for 1 hour or 2 hours. The results obtained in this fundamental study led to the suggestion that the proper dosage in bacterial infections would be 50 approximately 100 mg/kg intravenously in 3 approximately 4 divided doses daily. 2) A clinical study of PC-904 was performed in 16 patients including acute pharyngitis and bronchitis (3 cases), acute bronchopneumonia (3 cases), pertussis pneumonia (1 case), lymphadenitis purulenta (2 cases), acute bronchopneumonia (3 cases), pertussis pneumonia (1 case), lymphadenitis purulenta (2 cases), abscess with chronic granuloma (2 cases) and urinary tract infection (5 cases). About 50 approximately 100 mg/kg of PC-904 were administered in 3 approximately 4 divided doses daily by one-shot intravenous injection. The clinical effects of 2 cases out of 16 were impossible to be evaluated, and thses cases were excluded from the clinical evaluation. Ten cases out of 14 showed excellent or good responses (efficacy rate: 71.4%). 3) The bacteriological examinations were performed and the causative or isolated organisms were determined in 11 cases. The responses were "disappeared" in 6 cases, "decreased" in 2 cases and "not disappeared" in 3 cases. 4) No side effects were observed. Abnormalities of laboratory findings were not also noticed.

摘要

对儿童进行了PC - 904的临床研究。结果如下:1)通过单次静脉注射或静脉滴注1小时或2小时,对单次给予20mg/kg后的患者血清PC - 904水平进行了研究。该基础研究的结果表明,细菌感染的合适剂量为每日静脉注射50至100mg/kg,分3至4次给药。2)对16例患者进行了PC - 904的临床研究,包括急性咽炎和支气管炎(3例)、急性支气管肺炎(3例)、百日咳肺炎(1例)、脓性淋巴结炎(2例)、急性支气管肺炎(3例)、百日咳肺炎(1例)、脓性淋巴结炎(2例)、慢性肉芽肿性脓肿(2例)和尿路感染(5例)。通过单次静脉注射,每日分3至4次给予约50至100mg/kg的PC - 904。16例中有2例的临床效果无法评估,这些病例被排除在临床评估之外。14例中有10例显示出优异或良好的反应(有效率:71.4%)。3)进行了细菌学检查,并在11例中确定了病原体或分离出的微生物。6例反应为“消失”,2例为“减少”,3例为“未消失”。4)未观察到副作用。实验室检查结果也未发现异常。

相似文献

1
[A clinical study of PC-904 in pediatrics (author's transl)].PC - 904在儿科的临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):389-94.
2
[Clinical study of PC-904 in pediatrics (author's transl)].PC - 904在儿科的临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):383-8.
3
[Fundamental and clinical studies in pediatrics on PC-904, a penicillin with broad spectrum newly developed in Japan (author's transl)].日本新研制的广谱青霉素PC - 904的儿科学基础与临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):371-82.
4
[Basic and clinical studies on new semisynthetic penicillin, PC-904, in pediatric field (author's transl)].新型半合成青霉素PC - 904在儿科领域的基础与临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):401-18.
5
[Fundamental and clinical studies of PC-904 in pediatrics (author's transl)].PC - 904在儿科的基础与临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):366-70.
6
[A clinical study of PC-904 in pediatric field (author's transl)].PC-904在儿科领域的临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):363-5.
7
[Clinical studies of PC-904 in pediatrics (author's transl)].PC - 904在儿科中的临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):427-36.
8
[Clinical studies of PC 904 in pediatrics (author's transl)].PC 904在儿科的临床研究(作者译)
Jpn J Antibiot. 1978 Jul;31(7):395-400.
9
[Clinical evaluation of intravenous administration of ampicillin-oxacillin (Broadcillin 'Banyu') in bacterial infections in children (author's transl)].氨苄西林-苯唑西林静脉给药(泛宇牌“广谱西林”)治疗儿童细菌感染的临床评估(作者译)
Jpn J Antibiot. 1978 May;31(5):235-48.
10
[Laboratory and clinical studies on cefoxitin in pediatric field (author's transl)].
Jpn J Antibiot. 1981 Mar;34(3):287-304.